BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26822124)

  • 1. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
    Michael E; Singh BK
    BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.
    Michael E; Singh BK; Mayala BK; Smith ME; Hampton S; Nabrzyski J
    BMC Med; 2017 Sep; 15(1):176. PubMed ID: 28950862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
    Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
    BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.
    Singh BK; Michael E
    Parasit Vectors; 2015 Oct; 8():522. PubMed ID: 26490350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea.
    Singh BK; Bockarie MJ; Gambhir M; Siba PM; Tisch DJ; Kazura J; Michael E
    PLoS One; 2013; 8(6):e67004. PubMed ID: 23826185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework.
    Smith ME; Singh BK; Irvine MA; Stolk WA; Subramanian S; Hollingsworth TD; Michael E
    Epidemics; 2017 Mar; 18():16-28. PubMed ID: 28279452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
    Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
    Kastner RJ; Sicuri E; Stone CM; Matwale G; Onapa A; Tediosi F
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005934. PubMed ID: 28949987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic filariasis in Asia: a systematic review and meta-analysis.
    Bizhani N; Hashemi Hafshejani S; Mohammadi N; Rezaei M; Rokni MB
    Parasitol Res; 2021 Feb; 120(2):411-422. PubMed ID: 33415391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulating a Transmission Assessment Survey: An evaluation of current methods used in determining the elimination of the neglected tropical disease, Lymphatic Filariasis.
    Weiss PS; Michael E; Richards FO
    Int J Infect Dis; 2021 Jan; 102():422-428. PubMed ID: 33130207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.
    Michael E; Sharma S; Smith ME; Touloupou P; Giardina F; Prada JM; Stolk WA; Hollingsworth D; de Vlas SJ
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006674. PubMed ID: 30296266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.
    Gambhir M; Michael E
    PLoS One; 2008 Aug; 3(8):e2874. PubMed ID: 18716676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale.
    Touloupou P; Fronterre C; Cano J; Prada JM; Smith M; Kontoroupis P; Brown P; Rivera RC; de Vlas SJ; Gunawardena S; Irvine MA; Njenga SM; Reimer L; Seife F; Sharma S; Michael E; Stolk WA; Pulan R; Spencer SEF; Hollingsworth TD
    Clin Infect Dis; 2024 Apr; 78(Supplement_2):S108-S116. PubMed ID: 38662704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic performance and cost-effectiveness of using a DEC-salt social enterprise for eliminating the major neglected tropical disease, lymphatic filariasis.
    Sharma S; Smith ME; Reimer J; O'Brien DB; Brissau JM; Donahue MC; Carter CE; Michael E
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007094. PubMed ID: 31260444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic filariasis in Papua New Guinea: prospects for elimination.
    Bockarie MJ; Kazura JW
    Med Microbiol Immunol; 2003 Feb; 192(1):9-14. PubMed ID: 12592558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
    Fang Y; Zhang Y
    Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting lymphatic filariasis elimination in data-limited settings: A reconstructive computational framework for combining data generation and model discovery.
    Smith ME; Griswold E; Singh BK; Miri E; Eigege A; Adelamo S; Umaru J; Nwodu K; Sambo Y; Kadimbo J; Danyobi J; Richards FO; Michael E
    PLoS Comput Biol; 2020 Jul; 16(7):e1007506. PubMed ID: 32692741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis.
    Harris JR; Wiegand RE
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005610. PubMed ID: 28542274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.